TY - JOUR
T1 - Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1
AU - Ono, Masahiro
AU - Yaguchi, Hiroko
AU - Ohkura, Naganari
AU - Kitabayashi, Issay
AU - Nagamura, Yuko
AU - Nomura, Takashi
AU - Miyachi, Yoshiki
AU - Tsukada, Toshihiko
AU - Sakaguchi, Shimon
PY - 2007/4/5
Y1 - 2007/4/5
N2 - Naturally arising CD25+CD4+ regulatory T cells (TR cells) are engaged in the maintenance of immunological self-tolerance and immune homeostasis by suppressing aberrant or excessive immune responses, such as autoimmune disease and allergy. TR cells specifically express the transcription factor Foxp3, a key regulator of T R-cell development and function. Ectopic expression of Foxp3 in conventional T cells is indeed sufficient to confer suppressive activity, repress the production of cytokines such as interleukin-2 (IL-2) and interferon-gamma (IFN-γ), and upregulate TR-cell-associated molecules such as CD25, cytotoxic T-lymphocyte-associated antigen-4, and glucocorticoid-induced TNF-receptor-family-related protein. However, the method by which Foxp3 controls these molecular events has yet to be explained. Here we show that the transcription factor AML1 (acute myeloid leukaemia 1)/Runx1 (Runt-related transcription factor 1), which is crucially required for normal haematopoiesis including thymic T-cell development, activates IL-2 and IFN-γ gene expression in conventional CD4+ T cells through binding to their respective promoters. In natural TR cells, Foxp3 interacts physically with AML1. Several lines of evidence support a model in which the interaction suppresses IL-2 and IFN-γ production, upregulates TR-cell-associated molecules, and exerts suppressive activity. This transcriptional control of TR-cell function by an interaction between Foxp3 and AML1 can be exploited to control physiological and pathological T-cell-mediated immune responses.
AB - Naturally arising CD25+CD4+ regulatory T cells (TR cells) are engaged in the maintenance of immunological self-tolerance and immune homeostasis by suppressing aberrant or excessive immune responses, such as autoimmune disease and allergy. TR cells specifically express the transcription factor Foxp3, a key regulator of T R-cell development and function. Ectopic expression of Foxp3 in conventional T cells is indeed sufficient to confer suppressive activity, repress the production of cytokines such as interleukin-2 (IL-2) and interferon-gamma (IFN-γ), and upregulate TR-cell-associated molecules such as CD25, cytotoxic T-lymphocyte-associated antigen-4, and glucocorticoid-induced TNF-receptor-family-related protein. However, the method by which Foxp3 controls these molecular events has yet to be explained. Here we show that the transcription factor AML1 (acute myeloid leukaemia 1)/Runx1 (Runt-related transcription factor 1), which is crucially required for normal haematopoiesis including thymic T-cell development, activates IL-2 and IFN-γ gene expression in conventional CD4+ T cells through binding to their respective promoters. In natural TR cells, Foxp3 interacts physically with AML1. Several lines of evidence support a model in which the interaction suppresses IL-2 and IFN-γ production, upregulates TR-cell-associated molecules, and exerts suppressive activity. This transcriptional control of TR-cell function by an interaction between Foxp3 and AML1 can be exploited to control physiological and pathological T-cell-mediated immune responses.
UR - http://www.scopus.com/inward/record.url?scp=34247215187&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34247215187&partnerID=8YFLogxK
U2 - 10.1038/nature05673
DO - 10.1038/nature05673
M3 - Article
C2 - 17377532
AN - SCOPUS:34247215187
SN - 0028-0836
VL - 446
SP - 685
EP - 689
JO - Nature
JF - Nature
IS - 7136
ER -